|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 47/38 | (2013.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 31/18 | (2013.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/1605 | (2013.01) | ||
| A61K 31/18 | (2006.01) | ||
| A61K 9/5021 | (2013.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61K 9/1635 | (2013.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 31/4725 | (2006.01) | ||
| A61K 47/32 | (2013.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/4725 | (2013.01) |
| (11) | Number of the document | 3498264 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17839879.8 |
| Date of filing the European patent application | 2017-08-11 | |
| (97) | Date of publication of the European application | 2019-06-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2017/008800 |
| Date | 2017-08-11 |
| (87) | Number | WO 2018/030862 |
| Date | 2018-02-15 |
| (30) | Number | Date | Country code |
| 20160103269 | 2016-08-12 | KR |
| (72) |
KIM, Jae Ho , KR
LEE, Benjamin Joon , KR
KIM, Jin Cheul , KR
KIM, Yong Il , KR
PARK, Jae Hyun , KR
WOO, Jong Soo , KR
|
| (73) |
Hanmi Pharm. Co., Ltd. ,
214 Muha-ro
Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536,
KR
|
| (54) | PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED DISSOLUTION RATE, THE PREPARATION COMPRISING TAMSULOSIN HYDROCHLORIDE-CONTAINING SUSTAINED-RELEASE PELLETS |
| PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED DISSOLUTION RATE, THE PREPARATION COMPRISING TAMSULOSIN HYDROCHLORIDE-CONTAINING SUSTAINED-RELEASE PELLETS |